Nitrosative stress in Parkinson's disease

MG Stykel, SD Ryan - npj Parkinson's Disease, 2022 - nature.com
Parkinson's Disease (PD) is a neurodegenerative disorder characterized, in part, by the loss
of dopaminergic neurons within the nigral-striatal pathway. Multiple lines of evidence …

[HTML][HTML] The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders

MK Tripathi, M Kartawy, H Amal - Redox Biology, 2020 - Elsevier
Nitric oxide (NO) is a multifunctional signalling molecule and a neurotransmitter that plays
an important role in physiological and pathophysiological processes. In physiological …

l‐DOPA‐induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?

E Del‐Bel, M Bortolanza, M Dos‐Santos‐Pereira… - Synapse, 2016 - Wiley Online Library
Inflammation in Parkinson's disease (PD) is a new concept that has gained ground due to
the potential of mitigating dopaminergic neuron death by decreasing inflammation. The …

An update on the role of nitric oxide in the neurodegenerative processes of Parkinson's disease

F Javier Jimenez-Jimenez… - Current medicinal …, 2016 - ingentaconnect.com
Background: The pathogenesis of Parkinson's disease (PD) is not fully understood. Together
with some important physiological functions in the Central Nervous System (CNS), nitric …

Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by l-DOPA?

M Bortolanza, FE Padovan-Neto… - … of the Royal …, 2015 - royalsocietypublishing.org
Inflammatory mechanisms are proposed to play a role in l-DOPA-induced dyskinesia.
Cyclooxygenase-2 (COX2) contributes to inflammation pathways in the periphery and is …

Neuronal nitric oxide synthase and post-translational modifications in the development of central nervous system diseases: Implications and regulation

C Maccallini, R Amoroso - Molecules, 2023 - mdpi.com
In the Central Nervous System (CNS), Nitric Oxide (NO) is mainly biosynthesized by
neuronal Nitric Oxide Synthase (nNOS). The dysregulated activation of nNOS in neurons is …

Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats

FE Padovan-Neto, R Cavalcanti-Kiwiatkoviski… - …, 2015 - Elsevier
It is well known that nitric oxide (NO) interacts with dopamine (DA) within the striatal circuitry.
The anti-dyskinetic properties of NO synthase (NOS) inhibitors demonstrate the importance …

Extrapyramidal Side Effects with Chronic Atypical Antipsychotic Can Be Predicted by Labeling Pattern of FosB and phosphoThr34-DARPP-32 in Nucleus Accumbens

SG Prieto, MC Almeida, JCS Silva, E Del-Bel… - Biomedicines, 2023 - mdpi.com
Extrapyramidal side effects (EPS) can be induced by neuroleptics that regulate the
expression of transcription factor FosB and dopaminergic mediator DARPP-32 in the …

7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate

MT Herrero, JE Yuste, L Cuenca-Bermejo… - Open …, 2023 - royalsocietypublishing.org
Nitric oxide (NO) plays a pivotal role in integrating dopamine transmission in the basal
ganglia and has been implicated in the pathogenesis of Parkinson disease (PD). The …

Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: study on electrophysiological and behavioral models of temporal …

F Carletti, G Gambino, V Rizzo, G Ferraro, P Sardo - Neuroscience, 2015 - Elsevier
A growing bulk of evidence suggests that cannabinoid system plays a pivotal role in the
control of hyperexcitability phenomena. Notwithstanding, the anticonvulsant action of …